Blue Sky Asset Management LLC Buys New Position in LifePoint Health, Inc. (NASDAQ:LPNT)
Blue Sky Asset Management LLC acquired a new position in LifePoint Health, Inc. (NASDAQ:LPNT) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 11,040 shares of the company’s stock, valued at approximately $741,000.
A number of other large investors have also modified their holdings of LPNT. LS Investment Advisors LLC boosted its stake in shares of LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after buying an additional 543 shares in the last quarter. US Bancorp DE boosted its stake in shares of LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock worth $127,000 after buying an additional 30 shares in the last quarter. Bank of Montreal Can boosted its stake in shares of LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock worth $128,000 after buying an additional 306 shares in the last quarter. Teacher Retirement System of Texas acquired a new stake in shares of LifePoint Health during the first quarter worth about $210,000. Finally, Regent Investment Management LLC acquired a new stake in shares of LifePoint Health during the first quarter worth about $230,000. Hedge funds and other institutional investors own 99.59% of the company’s stock.
Shares of LifePoint Health, Inc. (NASDAQ LPNT) traded up 1.14% on Friday, hitting $57.45. 436,008 shares of the stock were exchanged. The company has a 50-day moving average price of $61.96 and a 200-day moving average price of $62.71. The firm has a market capitalization of $2.30 billion, a PE ratio of 12.86 and a beta of 0.86. LifePoint Health, Inc. has a one year low of $50.60 and a one year high of $70.95.
LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.90 by $0.06. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The business’s revenue for the quarter was up .2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.69 EPS. Equities research analysts expect that LifePoint Health, Inc. will post $4.07 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This piece was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/19/blue-sky-asset-management-llc-purchases-new-position-in-lifepoint-health-inc-nasdaqlpnt-updated.html.
A number of equities research analysts recently issued reports on the stock. Leerink Swann upgraded shares of LifePoint Health from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $73.00 to $74.00 in a report on Tuesday, June 6th. BidaskClub cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Saturday, July 8th. Royal Bank Of Canada reissued a “buy” rating and set a $77.00 target price on shares of LifePoint Health in a research report on Wednesday, July 5th. Zacks Investment Research raised shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 target price for the company in a research report on Tuesday, July 4th. Finally, TheStreet lowered shares of LifePoint Health from a “b-” rating to a “c+” rating in a research report on Wednesday. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $66.18.
In other LifePoint Health news, Chairman William F. Carpenter III sold 82,347 shares of the business’s stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the sale, the chairman now directly owns 504,535 shares of the company’s stock, valued at approximately $32,365,920.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman William F. Carpenter III sold 17,653 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the sale, the chairman now directly owns 439,841 shares in the company, valued at $28,616,055.46. The disclosure for this sale can be found here. 7.28% of the stock is currently owned by insiders.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Stock Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related stocks with our FREE daily email newsletter.